Zybiraa (Abiraterone 250 Mg Tablets 120’S) is a medication used for the treatment of prostate cancer in men. It is an androgen biosynthesis inhibitor that decreases the production of testosterone, a hormone that is known to induce the growth of prostate cancer cells. The medication is taken orally in the form of tablets.
Each tablet of Zybiraa contains abiraterone acetate as the active ingredient. Other ingredients include microcrystalline cellulose, colloidal silicon dioxide, magnesium stearate, hypromellose, polyethylene glycol, and titanium dioxide.
Zybiraa is an effective medication used to treat prostate cancer in men who have not responded well to other treatments. It is used in combination with other medications to reduce the production of testosterone in the body, which helps reduce the growth and spread of prostate cancer.
Usage and Dosage:
Zybiraa is a prescription medication that should be taken as directed by a healthcare professional. The recommended dosage for most patients is one tablet of 250mg per day, taken orally on an empty stomach. The medication should be taken at least 1 hour before or 2 hours after eating. The dosage may be adjusted based on the patient’s response to treatment.
Zybiraa should be stored in a cool, dry place at room temperature (15°C to 30°C) away from direct sunlight. The medication should be kept out of reach of children and pets.
Mechanism of Action:
Abiraterone, the active ingredient in Zybiraa, works by blocking an enzyme called CYP17, which is responsible for the production of androgens like testosterone. By inhibiting the production of androgens, Zybiraa helps slow down the growth and spread of prostate cancer cells in the body.
Zybiraa is contraindicated in patients who are allergic to abiraterone acetate or any of the other ingredients in the medication. It should not be used in women who are pregnant or breastfeeding.
Zybiraa may interact with other medications, including corticosteroids like prednisone, which are sometimes used in combination with abiraterone. Patients should inform their healthcare provider of any medications, vitamins, or supplements they are taking before starting treatment with Zybiraa.
Common side effects of Zybiraa include fatigue, joint pain, nausea, diarrhea, vomiting, and high blood pressure. In some cases, allergic reactions may occur. Patients should contact their healthcare provider immediately if they experience any symptoms of an allergic reaction, including swelling of the face, lips, tongue, or throat, difficulty breathing, or hives.
Zybiraa is the brand name for abiraterone acetate tablets manufactured by Panacea Biotec Ltd.